Avalon Capital is a corporate finance advisory firm providing investment banking services to international companies and private equity funds. We specialize in serving middle-market and emerging growth companies that seek exits, strategic acquisitions as well as financial investors seeking a “buy and build” strategy.
Our corporate finance advisory services enable Israeli companies and their shareholders to maximize their return on investment and free management from the time-consuming details of managing an M&A process in order to concentrate on running the business.
As a leading advisor to Israeli companies that wish to expand internationally, we leverage our familiarity with the Israeli venture capital community and foreign groups in order to provide a wide range of cross-border advisory services. These include Mergers & Acquisitions, the placement of private equity and debt, and Initial Public Offerings.
We have closed numerous deals with growth companies by accessing investors from both sides of the Atlantic. With headquarters in Israel, we have a deep international network to search and target M&A opportunities from both a buy-side and sell-side perspective.
Avalon actively represents US and European companies in their quest for growth via M&A of Israel high-tech stars. The compelling story is the attractiveness that stems from innovation, strong R&D, first mover advantage, good management, and entrants into new markets.
Avalon Advises Surgical Navigation Software Company on Sale to Stryker
October 27, 2013
Avalon Capital is pleased to announce that Stryker, has acquired ActiViews, a privately held Israeli medical device company. Avalon Capital acted as the financial advisor for ActiViews for the transaction. ActiViews is a developer of innovative image guided surgical navigation tools. Stryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The acquisition will combine ActiViews’ high tech product line of surgical tools with Stryker’s leading line of medical devices and equipment, to create an enhanced portfolio of products for image guided surgery. ActiViews looked to Avalon Capital's cross border transaction expertise to accomplish their specific goals in connection with a prospective investor in connection with the sale of the company.
ActiViews is a high tech medical device company that provides navigation solutions that enhance performance in minimally invasive surgical oncology procedures. ActiViews’ patented technology focuses on CT-Guide® navigation, their flagship product. It is the first and only system available specifically for CT-guided lung and liver interventions and has received a CE Mark, Chinese SFDA approval, and a Canadian Medical Device Establishment License. ActiViews addresses a large market opportunity with strong market fundamentals along with an experienced management team. ActiViews was founded in 2007 with headquarters in Haifa, Israel.
Stryker focuses on three medical segments: Reconstructive, MedSurg, and Neurotechnology & Spine. Their wide range of capabilities includes joint replacements, trauma, spine and micro implants systems, orthobiologics, powered surgical instruments, surgical navigation systems, endoscopic products as well as patient handling and emergency medical equipment. Stryker’s products are sold in over 100 countries with the US representing 65% of sales. Stryker was founded in 1941 and its headquarters are located in Kalamazoo, Michigan.
About Avalon Capital
Avalon Capital is a corporate finance advisory firm specializing in cross-border mergers and acquisitions for Israeli high tech companies with a concentration on US and European acquirers. Avalon is highly regarded in particular technology niches including wireless equipment, medical devices, cleantech, fintech software and information technology. The firm was founded in 2004 and is based in Tel Aviv. Avalon Capital applies partner level experience to the successful execution of advisory and financing transactions for emerging tech companies.